Detalhe da pesquisa
1.
A Standardized Approach for Collection of Objective Data to Support Outcome Determination for Late-Phase Tuberculosis Clinical Trials.
Am J Respir Crit Care Med
; 207(10): 1376-1382, 2023 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36790881
2.
Qualification of the differential leukocyte count and immunophenotyping in cryopreserved ex vivo whole blood assay.
Cytometry A
; 103(12): 992-1003, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37675607
3.
Predictors of virologic outcome among people living with HIV who continue a protease inhibitor-based antiretroviral regimen following virologic failure with no or limited resistance.
AIDS Res Ther
; 20(1): 3, 2023 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36604746
4.
High Asymptomatic Carriage With the Omicron Variant in South Africa.
Clin Infect Dis
; 75(1): e289-e292, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35353885
5.
Distinct rates and patterns of spread of the major HIV-1 subtypes in Central and East Africa.
PLoS Pathog
; 15(12): e1007976, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31809523
6.
Diverse Human Immunodeficiency Virus-1 Drug Resistance Profiles at Screening for ACTG A5288: A Study of People Experiencing Virologic Failure on Second-line Antiretroviral Therapy in Resource-limited Settings.
Clin Infect Dis
; 71(7): e170-e177, 2020 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31724034
7.
Discordance between Etravirine Phenotype and Genotype-Based Predicted Phenotype for Subtype C HIV-1 from First-Line Antiretroviral Therapy Failures in South Africa.
Antimicrob Agents Chemother
; 64(5)2020 04 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32071061
8.
Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100-200 cells/mm3.
BMC Infect Dis
; 20(1): 61, 2020 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31959112
9.
Comparable viral decay with initial dolutegravir plus lamivudine versus dolutegravir-based triple therapy.
J Antimicrob Chemother
; 74(8): 2365-2369, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31039247
10.
Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500 000 copies/mL: week 48 outcomes from ACTG 5353.
J Antimicrob Chemother
; 74(5): 1376-1380, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30668695
11.
ACTG A5353: A Pilot Study of Dolutegravir Plus Lamivudine for Initial Treatment of Human Immunodeficiency Virus-1 (HIV-1)-infected Participants With HIV-1 RNA <500000 Copies/mL.
Clin Infect Dis
; 66(11): 1689-1697, 2018 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29253097
12.
Key Factors Influencing the Emergence of Human Immunodeficiency Virus Drug Resistance in Low- and Middle-Income Countries.
J Infect Dis
; 216(suppl_9): S851-S856, 2017 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29207000
13.
Frequent Cross-Resistance to Dapivirine in HIV-1 Subtype C-Infected Individuals after First-Line Antiretroviral Therapy Failure in South Africa.
Antimicrob Agents Chemother
; 61(2)2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27895013
14.
Phenotype, Genotype, and Drug Resistance in Subtype C HIV-1 Infection.
J Infect Dis
; 213(2): 250-6, 2016 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26175454
15.
Predicting resistance as indicator for need to switch from first-line antiretroviral therapy among patients with elevated viral loads: development of a risk score algorithm.
BMC Infect Dis
; 16: 280, 2016 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-27296625
16.
The use of digital PCR to improve the application of quantitative molecular diagnostic methods for tuberculosis.
BMC Infect Dis
; 16: 366, 2016 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27487852
17.
Lopinavir/Ritonavir Monotherapy as Second-line Antiretroviral Treatment in Resource-Limited Settings: Week 104 Analysis of AIDS Clinical Trials Group (ACTG) A5230.
Clin Infect Dis
; 60(10): 1552-8, 2015 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25694653
18.
Reply to Suthar et al.
J Infect Dis
; 219(4): 673-674, 2019 01 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-30307562
19.
Drug susceptibility and resistance mutations after first-line failure in resource limited settings.
Clin Infect Dis
; 59(5): 706-15, 2014 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24795328
20.
Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine.
J Infect Dis
; 207 Suppl 2: S70-7, 2013 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23687292